Document Type : Original Article
Authors
1 MSc Student, Student Research Committee, Faculty of Nursing and Midwifery, Sabzevar University of Medical Sciences, Sabzevar, Iran
2 Assistant Professor of Cardiology, Department of Cardiology, School of Medicine, Heshmatieh Hospital, Sabzevar, Sabzevar University of Medical Sciences, Sabzevar, Iran.
3 Ph.D Candidate, Department of Epidemiology and Biostatistics, School of Health, Tehran University of Medical Sciences, Tehran, Iran
4 Assistant Professor of Cardiology, Department of Cardiology, School of Medicine, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran
5 5. Associate Professor, Department of Nursing, School of Nursing and Midwifery, Iranian Research Center of Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, Iran
Abstract
Introduction: Post myocardial infarction (MI) depression can significantly impact treatment adherence. This study aims to investigate the relationship between post-MI depression and adherence to the treatment.
Materials and Methods: A correlational study was conducted on 200 patients with MI referred to Heshmat Hospital in Rasht and Heshmatieh Hospital in Sabzevar. Sampling was performed using a convenience method from March 2021 to March 2022. Data collection targeted patients experiencing mild to moderate depression one month after their heart attack, utilizing the Beck Depression Inventory and Modanlo Treatment Adherence Questionnaire. Data analysis was conducted using SPSS-26.
Results: Among the participants, 13% exhibited poor treatment adherence, while 86% demonstrated moderate adherence. The results of the t-test indicated that the average adherence score for individuals with post-MI depression was significantly higher than that of non-depressed individuals (P < 0.001).
Conclusion: Patients experiencing post-MI depression showed greater adherence to treatment, potentially reflecting the psychological impact of their condition. Due to the divergence of these results from other studies, further research is recommended.
Keywords
Main Subjects
- Martinez-Garcia G, Rodriguez-Ramos M, Santos-Medina M, Carrero-Vazquez AM, Chipi-Rodriguez Y. New model predicts in-hospital complications in myocardial infarction. Discoveries. 2022;10(1): e142. doi: 10.15190/d.2022.1
- Gong FF, Vaitenas I, Malaisrie SC, Maganti K. Mechanical complications of acute myocardial infarction: a review. JAMA cardiology. 2021;6(3):341-9. doi:10.1001/jamacardio.2020.3690
- Liblik K, Mulvagh SL, Hindmarch CC, Alavi N, Johri AM. Depression and anxiety following acute myocardial infarction in women. Trends in cardiovascular medicine. 2022;32(6):341-7. doi.org/10.1016/j.tcm.2021.07.005
- Parikh NS, Omran SS, Kamel H, Elkind MS, Willey J. Symptoms of depression and active smoking among survivors of stroke and myocardial infarction: an NHANES analysis. Preventive medicine. 2020;137:106131. doi: 10.1016/j.ypmed.2020.106131
- Zakeri MA, Khoshnood Z, Dehghan M, Abazari F. The effect of the Continuous Care Model on treatment adherence in patients with myocardial infarction: a randomised controlled trial. Journal of Research in Nursing. 2020;25(1):54-65. doi.org/10.1177/1744987119890666
- Wright Jr EE, Malone DC, Trujillo JM, Gill J, Huse S, Li X, et al. Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin. Journal of Managed Care & Specialty Pharmacy. 2022;28(6):592-603. DOI: 10.18553/jmcp.2022.21436
- Pietrzykowski Ł, Michalski P, Kosobucka A, Kasprzak M, Fabiszak T, Stolarek W, Siller-Matula JM, Kubica A. Medication adherence and its determinants in patients after myocardial infarction. Scientific reports. 2020;10(1):12028. doi.org/10.1038/s41598-020-68915-1
- Sefah IA, Essah DO, Kurdi A, Sneddon J, Alalbila TM, Kordorwu H, et al. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: Findings and implications for the future. JAC-Antimicrobial Resistance. 2021;3(2):dlab080. doi: 10.1093/jacamr/dlab080
- Liblik K, Mulvagh SL, Hindmarch CC, Alavi N, Johri AM. Depression and anxiety following acute myocardial infarction in women. Trends in cardiovascular medicine. 2022;32(6):341-7. doi.org/10.1016/j.tcm.2021.07.005
- Fan Y, Shen BJ, Tay HY. Depression, anxiety, perceived stress, and their changes predicted medical adherence over 9 months among patients with coronary heart disease. British Journal of Health Psychology. 2021;26(3):748-66. DOI: 10.1111/bjhp.12496
- Volpato E, Toniolo S, Pagnini F, Banfi P. The relationship between anxiety, depression and treatment adherence in chronic obstructive pulmonary disease: a systematic review. International Journal of Chronic Obstructive Pulmonary Disease. 2021:2001-21. DOI: 10.2147/COPD.S313841
- Gonzalez Heredia T, González-Ramírez LP, Hernández-Corona DM, Maciel-Hernández EA. Anxious depression in patients with Type 2 Diabetes Mellitus and its relationship with medication adherence and glycemic control. Global Public Health. 2021;16(3):460-8. DOI: 10.1080/17441692.2020.1810735
- Hamidi R, Fekrizadeh Z, Azadbakht M, Garmaroudi G, Taheri Tanjani P, Fathizadeh S, et al. Validity and reliability Beck Depression Inventory-II among the Iranian elderly population. Journal of Sabzevar University of Medical Sciences. 2015;22(1):189-98. doi: 10.1371/journal.pone.0199750
- Fatemi NS, Rafii F, Hajizadeh E, Modanloo M. Psychometric properties of the adherence questionnaire in patients with chronic disease: A mix method study. 2018; 20 (2) :179-191. URL: http://koomeshjournal.semums.ac.ir/article-1-4156-en.html
- Carney RM, Freedland KE. Depression and coronary heart disease. Nature Reviews Cardiology. 2017;14(3):145-55. available at: https://www.nature.com/articles/nrcardio.2016.181
- Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology. 1995;14(1):88. DOI: 10.1037//0278-6133.14.1.88
- Konstantinou P, Kassianos AP, Georgiou G, Panayides A, Papageorgiou A, Almas I, Wozniak G, Karekla M. Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development. Translational behavioral medicine. 2020;10(6):1390-8. doi.org/10.1093/tbm/ibaa118
- Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Archives of internal medicine. 2000;160(12):1818-23. DOI: 10.1001/archinte.160.12.1818
- Al-Zaru IM, Shahrour G, Masha'al D, Hayajneh AA. Depression and adherence to healthy lifestyle behaviors among patients with coronary artery diseases in Jordan. Heliyon. 2022;8(7) : e09752. doi: 10.1016/j.heliyon.2022.e09752
- He QH, Zheng J, Liu JL, Wang J, You LM. Predictors of Medication Adherence of Patients With Coronary Heart Disease After Percutaneous Coronary Intervention: A Structural Equation Modeling Based on the Extended Theory of Planned Behavior. Journal of Cardiovascular Nursing. 2022;37(4):350-358 doi: 10.1097/JCN.0000000000000755
- Vanzella LM, Pakosh M, Oh P, Ghisi GL. Health-related information needs and preferences for information of individuals with cardiovascular disease from underserved populations: A systematic review. Patient Education and Counseling. 2022;105(12):3398-409. DOI: 10.1016/j.pec.2022.09.008
)